Zhejiang Medicine Co., Ltd.

Zhejiang Medicine Co., Ltd. saw a decline in its stock today, contrasting with the broader market's modest decrease. Despite recent struggles, the company has reported positive results over the last four quarters and maintains a strong cash position, with a market capitalization of CNY 15,352 million.

Zhejiang Medicine Co., Ltd. has shown strong short-term performance, with notable increases over the past week and month, as well as a significant year-to-date rise. The company has reported positive quarterly results and maintains a solid cash position, despite facing long-term growth challenges in net sales.

Zhejiang Medicine Co., Ltd. saw a significant stock decline today, contrasting with the broader market's modest gain. Despite recent positive quarterly results and a strong cash position, the company has underperformed over the past year, with modest long-term growth in net sales.

Zhejiang Medicine Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. Despite recent positive quarterly results and a strong cash position, the company's one-year return lags behind the market. Long-term growth metrics indicate a need for strategic focus in the future.

Zhejiang Medicine Co., Ltd. has seen notable stock performance, gaining 7.86% on March 6, 2026, with an intraday high of CNY 18.54. The company has reported positive financial results over the past four quarters, maintaining a strong cash position and demonstrating resilience in the pharmaceuticals sector.

Zhejiang Medicine Co., Ltd. has seen a significant rise today, contrasting with a decline in the broader market. The company reported strong financial metrics, including substantial operating cash flow and a low debt-equity ratio, indicating a solid balance sheet despite underperforming the market over the past year.